US Patent Number
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.
Vermillion, Inc., Austin, TX (US), The University of Kentucky Research Foundation, Lexington, KY (US)
Fung, Eric T.; Ueland, Frederick; van Nagell, J. R.; Depriest, Paul D.; and Baron, Andre T., "Biomarkers for Ovarian Cancer" (2013). Epidemiology Faculty Patents. 1.